Patent Assignment
Reel/Frame 012918/0801
Assignment of Assignor's Interest
Recorded: 2002-05-21
Pages: 2
Assignor
HOWARD HUGHES MEDICAL INSTITUTE
Executed: 2002-04-29
Assignee
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 N.E. 13TH STREET, OKLAHOMA CITY, OKLAHOMA, 73104
Covered Property
(1)
Novel Component of Von Hippel-Lindau Tumor Suppressor Complex and Scf Ubiquitin Ligase
Patent:
6,858,709 →
Application:
09/914,324 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 21, 2002
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 012918/0569 →
Assignment of Assignor's Interest
May 21, 2002
From: CONAWAY, RONALD C.
To: OKLAHOMA MEDICAL RESEARCH FOUNDATION
Reel/Frame 012918/0796 →
Corrective Assignment to Correct the Execution Date: December 19, 1998 Previously Recorded on Reel 012918 Frame 0569. Assignor(S) Hereby Confirms the Execution Date: November 18, 1998 and November 19, 1998.
Jan 17, 2008
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 020385/0213 →
Confirmatory License
Jun 30, 2017
From: OKLAHOMA MEDICAL RESEARCH FOUNDATION
To: NIH-DEITR
Reel/Frame 042879/0106 →
Confirmatory License
Jul 3, 2017
From: OKLAHOMA MEDICAL RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043074/0744 →